Cobenfy (xanomeline/trospium) - BMS
Cholinergic Enhancement of Theta (clinicaltrials.gov) - Nov 15, 2025 - P1 | N=50 | Not yet recruiting | Sponsor: University of Texas Southwestern Medical Center 
New P1 trial • CNS Disorders • Cognitive Disorders • Epilepsy
http://clinicaltrials.gov/ct2/show/NCT07228338
 
Nov 15, 2025